Search

Your search keyword '"Campani C"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Campani C" Remove constraint Author: "Campani C"
157 results on '"Campani C"'

Search Results

1. Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy

3. Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma

5. Clinical impact of relative dose intensity of cabozantinib during the first 8 weeks and of subsequent dose reductions in patients with unresectable hepatocellular carcinoma

6. Outcomes of Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced hepatocellular carcinoma in the era of immunotherapy: A real-life comparison with best supportive care

8. MerTK-expressing macrophages promote the malignant features of cholangiocarcinoma cells

9. Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection

10. Hepatocyte depletion of ERK5 impairs the response to lipotoxic oxidative stress resulting in defective insulin receptor signaling

11. Incidence and risk factors of esophagogastric varices bleeding in cirrhotic patients with advanced hepatocellular carcinoma treated with lenvatinib

13. Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance

15. Pattern of macrovascular invasion in hepatocellular carcinoma

16. Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison

17. T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA

20. Transjugular intra-hepatic portosystemic shunt (TIPS) in elderly patients: preliminary analysis of a multicenter retrospective cohort.

21. Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study

23. Pattern of macrovascular invasion in hepatocellular carcinoma

24. The changing scenario of hepatocellular carcinoma in Italy: an update

25. Identification of clinical phenotypes and related survival in patients with large hccs

27. Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors

31. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study

32. Metabolic disorders across hepatocellular carcinoma in Italy

40. Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

41. Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma

42. Identification of clinical phenotypes and related survival in patients with large hccs

43. Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

44. Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib

45. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

46. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

47. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

48. Surveillance for hepatocellular carcinoma with a 3-months interval in 'extremely high-risk' patients does not further improve survival

49. Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison

50. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma

Catalog

Books, media, physical & digital resources